Clozapine toxicity: a cautionary palliative care tale

Area of Science:

• Pharmacology
• Psychiatry
• Palliative Care

Background:

• Cigarette smoking is known to induce certain drug-metabolizing enzymes, affecting medication efficacy.
• Clozapine, an atypical antipsychotic, has a narrow therapeutic index and is metabolized by CYP1A2, an enzyme affected by smoking.

Observation:

• A patient experiencing reduced smoking habit developed symptoms consistent with clozapine toxicity.
• The patient's presentation mimicked clinical deterioration typically seen in individuals nearing end of life.

Findings:

• Decreased smoking led to reduced metabolism of clozapine, resulting in drug accumulation and toxicity.
• The patient's condition significantly improved after adjusting clozapine dosage and changing antipsychotic medication.

Implications:

• Palliative care specialists must consider smoking status when managing patients on clozapine.
• Altered smoking habits can precipitate clozapine toxicity, presenting as apparent clinical decline.
• Early recognition and intervention are crucial for managing clozapine toxicity in this context.